SENIOR CLINICAL TRIAL ASSOCIATE

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

GENERAL JOB FUNCTIONS :

• Responsible for assisting with the planning and management of the operational aspects of clinical trials, including CRO and vendor management / oversight, ensuring project milestones and objectives are met and clinical study deliverables are consistent with program / company goals.
• Responsible for collecting, tracking, and reviewing investigator site regulatory documents for completion and accuracy, including FDFs, 1572's, CVs, medical licenses and other study specific documents as needed.
• Lead and drive TMF filing, management, oversight, & reconciliation activities, including interaction and coordination of all essential internal TMF contributing functions and the responsible CRO according to ICH-GCP, company SOPs and Wis
• Responsible for recording minutes for vendor, study team and site teleconferences, distributing for team review and consolidating comments into one document prior to submitting for finalization and distribution to the study team.
• Responsible for tracking regulatory and other essential study documents, CTA / budget status, site and vendor payments, SUSARs (safety letter) and monitoring visits / reports.
• Ensure in conjunction with the Clinical Trial Leader (CTL) that study related systems (Kura and / or CRO) are updated on a regular basis
• Assist study team in managing study start-up, conduct and close-out activities and other project related activities.
• Assist study team in the conduct of studies and ensure they are implemented according to the study protocols and in compliance with local, ICH, GCP and company policies and procedures.
• Assist study team to ensure clinical trials meet time, quality, and cost targets consistent with the overall Clinical Development Plan.
• Assist the CTLs / Study Teams / CST in preparation of Audits or Inspections and participate in Audit and Inspection interviews, as required
• Assist with monitoring study sites as needed
• Assist with ordering and tracking delivery and receipt of required study supplies and investigational product to study sites and provide regular status updates.
• Assist with organizing and managing project timelines and budgets; help ensure project deliverables are on time and within budget and amended; accordingly.
• Manage Purchase Orders, financial tracking, invoice processing, and other budgetary support in a timely manner and according set expectations. Set up contracts in Coupa as required and ensure all financial documentation is always Audit & Inspection ready
• Assist with oversight and tracking receipt of laboratory samples to the laboratory vendor(s)
• Assist with oversight of operational activities from start-up to close-out to ensure deliverables are prioritized and goals and objectives are met and / or changed accordingly.
• Assist with the development and review of study-related documents, including clinical protocols, ICFs, CRFs, monitoring plans, study, laboratory and pharmacy manuals, data management plans, etc.
• Assist with the review and approval of study site and vendor payments.
• Assist with tracking enrollment status and providing updates to study team and vendors.
• Assist with tracking program study drug inventory to ensure adequate drug supply available to support ongoing / future studies.
• Collaborate with internal and external team members for the planning and execution of clinical trials.
• Review study reporting both internally and externally for quality and accuracy of any relevant details required.
• Support clinical trial insurance activities on assigned trials
• Support CTLs in the surveillance of Kura company compliance in assigned studies / programs
• Support Inspection Readiness activities for priority projects, as assigned, including coordination of study oversight activities.
• Contribute to workshops / special initiatives as expert / professional for dedicated topics
• Maintain Study Team Lists
• Maintain SUSAR distribution lists and coordinate compliance reviews for assigned trials
• Maintain knowledge and usage of databases and platforms used by the department
• Prepare and hold presentations for training sessions, line managers meetings, department meetings, program or study meetings as required
• Provide knowledge and assistance with the Kura Medical Review Committee (MRC) review of clinical trial materials according to the MRC charter
• Complete other duties as assigned by the manager

SR. CTA EXPECTATIONS :

JOB SPECIFICATIONS :

Kura's Values that are used for candidate selection and performance assessments :

The Kura Package

Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company's diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology's approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.

Kura's pipeline consists of three investigational drug candidates : ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R / R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R / R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R / R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1 / 2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura's website at www.kuraoncology.com and follow us on X and LinkedIn.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.